KRISTY DAY: Open Payments
NPI 1750804001 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 23 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $422 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| ABBVIE INC. | 4 | $72 |
| Novo Nordisk Inc | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 1 | $19 |
Products named: CAPLYTA, TRINTELLIX, JARDIANCE, Veozah, Wegovy, UBRELVY, QULIPTA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
